Singapore markets closed

Swedish Orphan Biovitrum AB (B6E.HA)

Hanover - Hanover Delayed price. Currency in EUR
Add to watchlist
24.88+0.34 (+1.39%)
As of 08:01AM CEST. Market open.
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
17,696,000
22,123,000
18,790,000
15,529,000
15,261,000
Cost of revenue
4,484,000
4,995,000
4,776,000
3,484,000
3,225,000
Gross profit
13,212,000
17,128,000
14,014,000
12,045,000
12,036,000
Operating expenses
Research development
2,265,000
2,796,000
2,354,000
1,994,000
1,594,000
Selling general and administrative
7,550,000
10,161,000
7,847,000
6,294,000
5,981,000
Total operating expenses
9,735,000
12,948,000
10,169,000
8,258,000
7,573,000
Operating income or loss
3,477,000
4,180,000
3,845,000
3,787,000
4,463,000
Interest expense
-
1,111,000
458,000
419,000
454,000
Income before tax
2,978,000
2,954,000
3,321,000
3,295,000
4,217,000
Income tax expense
485,000
546,000
683,000
616,000
972,000
Income from continuing operations
2,493,000
2,408,000
2,638,000
2,679,000
3,245,000
Net income
2,493,000
2,409,000
2,638,000
2,679,000
3,245,000
Net income available to common shareholders
2,493,000
2,409,000
2,638,000
2,679,000
3,245,000
Basic EPS
8.92
7.47
8.52
8.67
10.52
Diluted EPS
8.84
7.39
8.44
8.63
10.41
Basic average shares
310,393
322,659
309,478
308,899
308,487
Diluted average shares
313,429
325,968
312,455
310,729
311,609